Sign In
Buy OGN
$13.40
+0.0200 (+0.149%)
At Close: Jun 03, 2026
Organon (OGN) Stock Declines While Market Improves: Some Information for Investors
06:55pm, Friday, 21'st Mar 2025
In the closing of the recent trading day, Organon (OGN) stood at $15.39, denoting a -1.35% change from the preceding trading day.
Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know
10:05am, Wednesday, 19'th Mar 2025
Recently, Zacks.com users have been paying close attention to Organon (OGN). This makes it worthwhile to examine what the stock has in store.
Organon (OGN) Advances While Market Declines: Some Information for Investors
07:06pm, Tuesday, 18'th Mar 2025
Organon (OGN) concluded the recent trading session at $15.70, signifying a +0.51% move from its prior day's close.
Why Organon Is A Top Pick For Income Investors
10:58pm, Monday, 17'th Mar 2025
In mid-February, Organon pleasantly surprised me with its financial results for the fourth quarter of 2024. So, sales of Hadlima, a biosimilar to Humira, amounted to $44 million in the last three mont
JERSEY CITY, N.J.--(BUSINESS WIRE)--Organon (NYSE: OGN), a global healthcare company with a focus on women's health, today announced results from an analysis of the Phase 3 ADORING 3 open-label, long-
High-Yield Healthcare: 3 Stocks With Strong Dividends
07:16am, Sunday, 16'th Feb 2025
When it comes to dividend performers, healthcare usually takes a backseat to options like REITs and energy stocks. However, the sector's resilience, driven by aging populations and consistent demand
Organon & Co. (OGN) Q4 2024 Earnings Call Transcript
12:47pm, Thursday, 13'th Feb 2025
Organon & Co. (NYSE:OGN ) Q4 2024 Earnings Conference Call February 13, 2025 8:30 AM ET Company Participants Jennifer Halchak - VP, IR Kevin Ali - CEO Juan Camilo Arjona Ferreira - Head of R&D Matt Wa
Organon (OGN) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
11:31am, Thursday, 13'th Feb 2025
The headline numbers for Organon (OGN) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estima
Organon (OGN) Q4 Earnings and Revenues Beat Estimates
09:46am, Thursday, 13'th Feb 2025
Organon (OGN) came out with quarterly earnings of $0.90 per share, beating the Zacks Consensus Estimate of $0.86 per share. This compares to earnings of $0.88 per share a year ago.
Organon Reports Results for the Fourth Quarter and Full Year Ended December 31, 2024
07:30am, Thursday, 13'th Feb 2025
JERSEY CITY, N.J.--(BUSINESS WIRE)--Organon announces Q4 2024 and Full Year 2024 earnings results, ending December 31, 2024.
Why Organon (OGN) Dipped More Than Broader Market Today
06:50pm, Friday, 07'th Feb 2025
Organon (OGN) concluded the recent trading session at $14.62, signifying a -1.81% move from its prior day's close.
Organon (OGN) Rises Higher Than Market: Key Facts
06:56pm, Thursday, 30'th Jan 2025
The latest trading day saw Organon (OGN) settling at $15.97, representing a +0.82% change from its previous close.
Organon (OGN) Increases Despite Market Slip: Here's What You Need to Know
07:06pm, Monday, 27'th Jan 2025
Organon (OGN) closed at $16.26 in the latest trading session, marking a +1.82% move from the prior day.
Organon To Report Fourth Quarter and Full Year 2024 Results and Host Conference Call on February 13, 2025
07:30am, Thursday, 23'rd Jan 2025
JERSEY CITY, N.J.--(BUSINESS WIRE)--Organon To Report Fourth Quarter and Full Year 2024 Results and Host Conference Call on February 13, 2025.
Organon (OGN) Surpasses Market Returns: Some Facts Worth Knowing
07:05pm, Tuesday, 21'st Jan 2025
Organon (OGN) closed the most recent trading day at $15.88, moving +0.89% from the previous trading session.
